Authors: Gordon, MS Margolin, K Talpaz, M Sledge, GW Holmgren, E Benjamin, R Stalter, S Shak, S Adelman, DC

Citation: Ms. Gordon et al., Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer, J CL ONCOL, 19(3), 2001, pp. 843-850

Authors: Margolin, K Gordon, MS Holmgren, E Gaudreault, J Novotny, W Fyfe, G Adelman, D Stalter, S Breed, J

Citation: K. Margolin et al., Phase Ib trial of intravenous recombinant humanized monoclonal antibody tovascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: Pharmacologic and long-term safety data, J CL ONCOL, 19(3), 2001, pp. 851-856